Eli Lilly selects Pennsylvania for $3.5bn obesity drugs manufacturing site
Eli Lilly has chosen Pennsylvania to house a new $3.5bn manufacturing facility that will produce a forthcoming wave of new…
News
Amgen hands back eczema drug to Kyowa Kirin despite positive late-stage data
CHMP grants positive opinion for J&J’s Akeega use
CIRM unveils RAPID funding programme for rare diseases
FDA’s new scheme to boost US manufacturing commences despite uncertainty
Sanofi touts strong new launch sales amid looming Dupixent patent expiry
AstraZeneca signs $18.5bn weight loss drug deal with CSPC
IQVIA and Boehringer Ingelheim collaborate on therapeutic data transformation
